Victory Value holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Victory Value Fund UVALX
- NAV / 1-Day Return 20.77 / −0.19 %
- Total Assets 1.4B
-
Adj. Expense Ratio
0.950%
- Expense Ratio 0.950%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 1.05%
- Turnover 50%
USD | NAV as of Jun 09, 2026 | 1-Day Return as of Jun 09, 2026, 12:11 AM GMT+0
Morningstar’s Analysis UVALX
Will UVALX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the UVALX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of UVALX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 3.10 | 42M | Communication Services |
JPMorgan Chase & Co | 2.43 | 33M | Financial Services |
Johnson & Johnson | 2.15 | 29M | Healthcare |
Cash | 1.76 | 24M | Cash and Equivalents |
Exxon Mobil Corp | 1.75 | 24M | Energy |
FedEx Corp | 1.66 | 23M | Industrials |
Valero Energy Corp | 1.62 | 22M | Energy |
The Cigna Group | 1.56 | 21M | Healthcare |
Teva Pharmaceutical Industries Ltd ADR | 1.53 | 21M | Healthcare |
KeyCorp | 1.41 | 19M | Financial Services |
United States